Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells
Open accessThe DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index; 45 of the 212 sources its claims cite were checked for support.
Abstract
Bone tissue is continuously remodeled through the concerted actions of bone cells, which include bone resorption by osteoclasts and bone formation by osteoblasts, whereas osteocytes act as mechanosensors and orchestrators of the bone remodeling process. This process is under the control of local (e.g., growth factors and cytokines) and systemic (e.g., calcitonin and estrogens) factors that all together contribute for bone homeostasis. An imbalance between bone resorption and formation can result in bone diseases including osteoporosis. Recently, it has been recognized that, during bone remodeling, there are an intricate communication among bone cells. For instance, the coupling from bone resorption to bone formation is achieved by interaction between osteoclasts and osteoblasts. Moreover, osteocytes produce factors that influence osteoblast and osteoclast activities, whereas osteocyte apoptosis is followed by osteoclastic bone resorption. The increasing knowledge about the structure and functions of bone cells contributed to a better understanding of bone biology. It has been suggested that there is a complex communication between bone cells and other organs, indicating the dynamic nature of bone tissue. In this review, we discuss the current data about the structure and functions of bone cells and the factors that influence bone remodeling.
Overview
CoChat Summary
TL;DR
This narrative review summarizes bone tissue biology, focusing on the structure and functions of osteoblasts, bone lining cells, osteocytes, and osteoclasts, the extracellular matrix, and local/systemic regulators of bone remodeling. It emphasizes cell–cell coupling, osteocyte mechanosensing, estrogen’s role, and emerging endocrine functions of bone.
Key findings
- Bone contains four cell types: osteoblasts (4–6% of total resident bone cells) form bone; osteocytes (90–95% of total bone cells, lifespan up to 25 years) act as mechanosensors and orchestrators; osteoclasts resorb bone; bone lining cells participate in coupling and the basic multicellular unit.
- The osteocyte lacunocanalicular system includes up to 50 cytoplasmic processes per cell; osteocyte surface is estimated to be 400-fold larger than all Haversian and Volkmann systems and more than 100-fold larger than trabecular bone surface; the lacunar space is about 0.5–1.0 μm wide and the canalicular membrane distance is 50–100 nm.
- Bone remodeling proceeds through initiation of resorption, a transition/reversal phase, and bone formation; coupling involves matrix-released factors such as IGFs, TGF-β, BMPs, FGF, and PDGF, plus semaphorins (Sema4D, Sema3A) and ephrinB2/EphB4, while imbalance can cause osteoporosis or osteopetrosis.
- Estrogen maintains bone homeostasis by inhibiting osteoblast and osteocyte apoptosis, suppressing osteoclast formation/activity, inducing osteoclast apoptosis, and modulating RANKL/OPG and cytokines; bone endocrine actions include undercarboxylated osteocalcin effects on pancreas, adipose tissue, testis, and brain, and osteocyte FGF23 regulation of phosphate metabolism.
Methods
- Design: narrative review; the authors state they discuss current data about bone cells, bone matrix, factors influencing bone remodeling, and estrogen under physiological and pathological conditions.
- Data or sample: no primary sample or dataset; evidence is drawn from cited in vitro and in vivo studies and prior literature.
- Main analysis: narrative synthesis of structural, molecular, and functional findings; no systematic search, meta-analysis, or new experiments are reported.
Limitations
- Stated in the paper: bone lining cell functions are not completely understood; mechanisms of osteocyte mechanosensing and the precise osteocyte-derived osteoclastogenesis-stimulating factors remain uncertain; direct in vivo contact between mature osteoblasts and osteoclasts has not been demonstrated and is controversial; bone endocrine function is still poorly understood.
- Evident from the text: as a narrative review, it lacks a systematic search strategy, risk-of-bias assessment, or quantitative synthesis, and its conclusions depend on the selected cited literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
23 Valid · 2 Not valid · 92 Not checked · 16 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“For instance, in bones subjected to fatigue loading, viable osteocytes near the apoptotic ones express, besides high RANKL/OPG ratio, increased levels of vascular endothelial growth factor (VEGF) and monocyte chemoattractant protein-1 (CCL2) promoting an increase in local osteoclastogenesis [194, 195].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.8. Bone Remodeling Process
What the sources say
- Partly supportedcites [194] matched to “Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations” (2012) sourceExperimental — accuracy not yet measured
Kennedy et al. (2012) support most of the sentence: the Abstract (p.1) and Results > Immunohistochemistry show RANKL and VEGF staining peaking 100-300 um from the damage site in non-apoptotic osteocytes while caspase-3+ cells dominate the damage core, and the Discussion states the RANKL/OPG ratio shift 'favoring osteoclast formation'. However, the candidate genes and IHC targets were only RANKL, OPG, VEGF and M-CSF (Materials and Methods > Gene expression analyses; Results > Gene expression) - CCL2/MCP-1 is neither measured nor mentioned anywhere in our copy (searched: CCL2, monocyte chemoattractant protein-1, MCP-1, chemokine), so that part of the claim is not attributable to this source. Also, the pro-osteoclastogenic conclusion is inferred from signaling patterns, since tissues were analyzed 3 and 7 days after fatigue, 'prior to the first appearance of osteoclasts'. (LLM, conf=0.85)
- Disputedcites [195] matched to “MCP-1 Expression Is Specifically Regulated During Activation of Skeletal Repair and Remodeling” (2013) sourceExperimental — accuracy not yet measured
Our copy places CCL2/MCP-1 expression in osteoblasts, not osteocytes: the Abstract reports that by in-situ hybridization and immunohistochemistry 'MCP-1 mRNA and protein was localized in periosteal osteoblasts associated with woven bone formation at the fracture exit point, but not within osteocytes adjacent to the SFx', and the Discussion likewise concludes MCP-1 is secreted by osteoblasts as a candidate signal attracting osteoclasts and their precursors. The paper's model is rat ulnar stress fracture initiation by cyclic end-loading, and it explicitly contrasts this with 'adaptive' ulnar loading; nowhere does our copy report viable osteocytes near apoptotic ones, nor any measurement of VEGF or of a high RANKL/OPG ratio in osteocytes (RANKL/OPG appears only as a downstream pathway shared with gp-130 cytokines such as IL-6/IL-11, Discussion). Thus the cellular source and the VEGF/RANKL-OPG components attributed to this source are contrary to, or absent from, our copy. (LLM, conf=0.80)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
None of the sources cited for this claim have been checked yet.
In the paper
“Bone lining cells functions are not completely understood, but it has been shown that these cells prevent the direct interaction between osteoclasts and bone matrix, when bone resorption should not occur, and also participate in osteoclast differentiation, producing osteoprotegerin (OPG) and the receptor activator of nuclear factor kappa-B ligand (RANKL) [14, 53].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.2. Bone Lining Cells
What the sources say
- Could not verifycites [14] matched to “A Physical Mechanism for Coupling Bone Resorption and Formation in Adult Human Bone” (2009) sourceExperimental — accuracy not yet measured
The Discussion describes bone-lining cells as poorly characterized and suggests they may be early osteoblast-lineage cells. It separately suggests that osteoblast precursors near differentiating pre-osteoclasts may express RANKL, but does not identify those precursors as bone-lining cells or say that bone-lining cells produce OPG. Searches for bone-lining cells with OPG, RANKL, and osteoclast differentiation found no passage establishing the claim. (LLM, conf=0.73)
- Not checked yetcites [53] 2000, Journal of Rehabilitation Research and Development
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Moreover, osteocyte apoptosis has been recognized as a chemotactic signal to osteoclastic bone resorption [70–73].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.3. Osteocytes
What the sources say
- Not checked yetcites [70] matched to “Identification of apoptotic changes in osteocytes in normal and pathological human bone” (1997) source
- Not checked yetcites [71] matched to “Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss.” (2006) source
- Supportedcites [72] matched to “Apoptotic Osteocytes and the Control of Targeted Bone Resorption” (2014) source
The section on osteocyte apoptosis and osteoclast recruitment states that apoptotic osteocytes recruit osteoclasts to initiate bone resorption. It also identifies HMGB1, released by apoptotic osteocytic cells, as chemotactic for osteoclasts, while noting that the signals responsible in vivo remain to be identified. (LLM, conf=0.86)
- Supportedcites [73] matched to “Osteocyte-Driven Bone Remodeling” (2014) source
In section 3, “Dying osteocytes,” the review says apoptotic osteocytes precede resorption and may act as beacons for osteoclast recruitment. It also describes a potential chemotactic factor released during osteocyte apoptosis. The claim reflects that proposed link without identifying a specific signal. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Other recent evidence is that osteoclasts may also directly regulate the hematopoietic stem cell niche [112].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.4. Osteoclasts
What the sources say
- Supportedcites [112] matched to “Osteoclasts: more than ‘bone eaters’” (2014) source
The HSC-niche section says osteoclasts may directly regulate the hematopoietic stem cell niche. The Concluding Remarks repeat this qualified claim while noting that conflicting reports remain to be resolved. (LLM, conf=0.95)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The systemic factors which are important to the maintenance of bone homeostasis include parathyroid hormone (PTH), calcitonin, 1,25-dihydroxyvitamin D3 (calcitriol), glucocorticoids, androgens, and estrogens [16, 147–150].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.7. Local and Systemic Factor That Regulate Bone Homeostasis
What the sources say
- Partly supportedcites [16] matched to “Estrogen and the skeleton” (2012) sourceExperimental — accuracy not yet measured
Our copy supports only the sex-steroid part of the attributed list: the Overview of estrogen action on bone states that 'estrogen is perhaps the major systemic regulator of bone metabolism not only in women, but also in men,' and the same section (citing Falahati-Nini et al., ref 5) and ref 31 address androgens/testosterone as systemic bone regulators. The other four factors named in the claim — parathyroid hormone, calcitonin, 1,25-dihydroxyvitamin D3 (calcitriol) and glucocorticoids — appear nowhere in our copy (searched: 'systemic factors parathyroid hormone calcitonin 1,25-dihydroxyvitamin D glucocorticoids', 'parathyroid hormone', 'calcitonin', 'glucocorticoids calcitonin vitamin D androgens'); every returned passage concerned estrogen actions, coupling factors in the bone remodeling compartment, or the reference list. Thus the paper does not enumerate the systemic hormonal repertoire the citing sentence attributes to it. (LLM, conf=0.72)
- Partly supportedcites [147] matched to “Activated parathyroid hormone/parathyroid hormone–related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone” (2001) sourceExperimental — accuracy not yet measured
The Introduction (p. 1) of Calvi et al. 2001 supports only the PTH element of the list: it describes PTH as 'a major regulator of calcium homeostasis' that 'plays an important role in both bone formation and resorption' in the context of factors controlling osteoblast/osteoclast balance. Our copy nowhere mentions calcitonin, 1,25-dihydroxyvitamin D3 (calcitriol), glucocorticoids, androgens, or estrogens as systemic factors maintaining bone homeostasis (searched: calcitonin; estrogen/glucocorticoid/systemic hormonal regulators; 1,25-dihydroxyvitamin D3), so the remaining five items attributed to this source are unsupported. The paper's scope is the local action of activated PTH/PTHrP receptor in osteoblastic cells on cortical versus trabecular bone in transgenic mice, not a survey of systemic hormonal regulators. (LLM, conf=0.72)
- Not checked yetcites [148] 2002, BMC Musculoskeletal Disorders
- Not checked yetcites [149] matched to “Forty years of calcitonin—where are we now? A tribute to the work of Iain Macintyre, FRS” (2002) source
- Not checked yetcites [150] matched to “Androgens and Bone” (2004) source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 12 with their cited sources checked
Create a free account to see all 133 claims and to verify the 167 references still open.
- It may state two separate claims as one. 40
- Probably not a substantial claim. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vivo, a set of osteoblasts, all with similar morphologies, lay down osteoid on active bone-forming surfaces.268”
From Bone remodeling: an operational process ensuring survival and bone mechanical competence (2022) · cites this paper as [268]
Citations
Cites
Stöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246 · cited 2×
“The expressions of Runtrelated transcription factors 2,Distal-less homeobox 5 (Dlx5), and osterix (Osx) are crucial for osteoblast differentiation [22, 26].”
BackgroundKomori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y.-H., Inada, M., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80258-5 · Cited by 4,244
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287 · cited 3×
“Besides osteoclasts and osteoblasts, it has been demonstrated that osteocytes play key roles during the bone remodeling cycle [8].”
BackgroundNormal Bone Anatomy and Physiology
Clarke, B. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04151206 · Cited by 2,192
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
Seeman, E., & Delmas, P. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra053077 · Cited by 2,080
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Takayanagi, H. (2007) · Nature Reviews Immunology · doi:10.1038/nri2062 · Cited by 1,878 · cited 2×
“Together, these factors promote the activation of transcription factors [81, 82] and gene expression in osteoclasts [83, 84].”
BackgroundFunctions of RANKL/RANK/OPG in bone modeling and remodeling
Boyce, B. F., & Xing, L. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.018 · Cited by 1,844 · cited 1×
“On the other hand, another factor called osteoprotegerin (OPG), which is produced by a wide range of cells including osteoblasts, stromal cells, and gingival and periodontal fibroblasts [87–89], binds to RANKL, preventing the RANK/RANKL interaction and, consequently, inhibiting the osteoclastogenesis [87] (Figure 5).”
Background
Research works printed but not linked: 15
- 2004, Histology and Histopathology, 19, 1325
- 1998, The nature of the mineral phase in bone, 23
- 1990, Bone-forming cells in clinical conditions, 351
- 1989, Scanning Microscopy, 3, 953
- 2000, Journal of Rehabilitation Research and Development, 37, 189
- 1999, The FASEB Journal, 13, S101
- 1999, Laboratory Investigation, 79, 83
- 2008, Journal of Musculoskeletal Neuronal Interactions, 8, 204
- 2005, Journal of Musculoskeletal Neuronal Interactions, 5, article 316
- 1972, Bone resorption and matrix hexosamine labeling, 327
- 2008, Integrins and adhesion molecules, 385
- 2004, Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 278, 505
- 2002, BMC Musculoskeletal Disorders, 7, 3
- 1997, Endocrine Society Journals and Publications, 82, 3128
- 2006, Journal of Musculoskeletal Neuronal Interactions, 6, 354
Cited by
Items 601–700 of 1,003
Macrophages in the process of osseointegration around the implant and their regulatory strategies
Fang, X., Sun, D., Li, Y., Xiao, H., Gan, Y., Jiao, J., Jiang, M., Gong, H., Qi, Y., & Zhao, J. (2024) · Connective Tissue Research · doi:10.1080/03008207.2023.2300455 · Cited by 24
Insulin Resistance and Pathogenesis of Postmenopausal Osteoporosis
Greere, D., Grigorescu, F., Manda, D. A., Lautier, C., & Poiană, C. (2023) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2023.349 · Cited by 24
Bioceramic materials in bone-implantable drug delivery systems: A review
Nayak, A. K., Maity, M., Barik, H., Behera, S. S., Dhara, A. K., & Hasnain, M. S. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105524 · Cited by 24
Zhen, C., Shi, Y., Wang, W., Zhou, G., Li, H., Lin, G., Wang, F., Tang, B., & Li, X. (2024) · Biofabrication · doi:10.1088/1758-5090/ad4595 · Cited by 25
Salamanna, F., Borsari, V., Contartese, D., Aldini, N. N., & Fini, M. (2018) · The Breast · doi:10.1016/j.breast.2018.06.013 · Cited by 24
Deletion of the Transcription Factor PGC-1α in Mice Negatively Regulates Bone Mass
Colaianni, G., Lippo, L., Sanesi, L., Brunetti, G., Celi, M., Cirulli, N., Passeri, G., Reseland, J. E., Schipani, E., Faienza, M. F., et al. (2018) · Calcified Tissue International · doi:10.1007/s00223-018-0459-4 · Cited by 24
Nie, Z., Wang, X., Ren, L., & Kang, Y. (2020) · Regenerative Medicine · doi:10.2217/rme-2019-0125 · Cited by 24
Zhu, H., Shi, Z., Cai, X.-Z., Yang, X., & Zhou, C. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9254 · Cited by 24
Li, A., Li, J., Zhang, Z., Li, Z., Chi, H., Song, C., Wang, X., Wang, Y., Chen, G., & Yan, J. (2021) · Journal of Materials Chemistry B · doi:10.1039/d0tb02554b · Cited by 24
Resveratrol induces proliferation in preosteoblast cell MC3T3-E1 via GATA-1 activating autophagy
Liu, X., Tao, J., Yao, Y., Yang, P., Wang, J., Yu, M., Hou, J., Zhang, Y., & Gui, L. (2021) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmab135 · Cited by 24
Ellagic acid and hydroxyapatite promote angiogenesis marker in bone defect
Nirwana, I., Munadziroh, E., Yuliati, A., Fadhila, A. I., Nurliana, Wardhana, A. S., Shariff, K. A., & Surboyo, M. D. C. (2021) · Journal of Oral Biology and Craniofacial Research · doi:10.1016/j.jobcr.2021.11.008 · Cited by 24
The role of long non‐coding RNAs and circular RNAs in bone regeneration: Modulating miRNAs function
Ping, J., Li, L., Dong, Y., Wu, X., Huang, X., Sun, B., Zeng, B., Xu, F., & Liang, W. (2022) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3277 · Cited by 24
Brown, M. E., & Puetzer, J. L. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.12.020 · Cited by 24
PIN1 is a new therapeutic target of craniosynostosis
Shin, H., Bae, H., Kim, B. S., Yoon, H. I., Cho, Y., Kim, W. J., Choi, K., Lee, Y., Woo, K. M., Baek, J., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy252 · Cited by 24
Methylglyoxal activates osteoclasts through JNK pathway leading to osteoporosis
Lee, K. M., Lee, C. Y., Zhang, G., Lü, A., & Yue, K. K. M. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.05.026 · Cited by 24
SiAlON–Al2O3 ceramics as potential biomaterials
Xie, H., Zhang, L., Xu, E., Yuan, H., Zhao, F., & Gao, J. (2019) · Ceramics International · doi:10.1016/j.ceramint.2019.05.221 · Cited by 24
Topography-based implants for bone regeneration: Design, biological mechanism, and therapeutics
Guo, W., Yang, Z., Liu, F., Song, J., Yang, W., Li, Y., Hu, W., & Wang, K. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102066 · Cited by 23
Ageing-Related Changes in Ultrastructural Bone Matrix Composition and Osteocyte Mechanosensitivity
Chen, Y., Klein‐Nulend, J., & Bravenboer, N. (2025) · Current Osteoporosis Reports · doi:10.1007/s11914-025-00927-0 · Cited by 23
Fu, J., Wei, T., Xiao, D., & Zhuang, X. (2025) · Archives of Computational Methods in Engineering · doi:10.1007/s11831-025-10313-9 · Cited by 23
Shi, R., Zhan, H., Jiang, S., Lin, K., & Yuan, C. (2025) · Advanced Science · doi:10.1002/advs.202511099 · Cited by 23
Chitosan-Based Biocomposite Scaffolds and Hydrogels for Bone Tissue Regeneration
Sekaran, S., Vimalraj, S., Lakshmanan, G., Jindal, A., Sundaramurthi, D., & Bhattacharya, J. (2019) · Springer series in biomaterials science and engineering · doi:10.1007/978-981-13-8855-2_18 · Cited by 23
Biomaterials for on-chip organ systems
Hassan, S., Heinrich, M. A., Çeçen, B., Prakash, J., & Zhang, Y. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102906-0.00019-2 · Cited by 23
Molecular Interactions between Dietary Lipids and Bone Tissue during Aging
Romero‐Márquez, J. M., Varela‐López, A., Navarro‐Hortal, M. D., Badillo-Carrasco, A., Forbes-Hernández, T. Y., Giampieri, F., Azpíroz, I. D., Madrigal, L., Battino, M. A., & Quiles, J. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126473 · Cited by 24
Nanodelivery Systems Face Challenges and Limitations in Bone Diseases Management
Giordano, F., Lenna, S., Rampado, R., Brozovich, A., Hirase, T., Tognon, M. G., Martini, F., Agostini, M., Yustein, J. T., & Taraballi, F. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100152 · Cited by 23
Silk–Inorganic Nanoparticle Hybrid Hydrogel as an Injectable Bone Repairing Biomaterial
Sun, L., Lu, M., Chen, L., Zhao, B., Yao, J., Shao, Z., Chen, X., & Liu, Y. (2023) · Journal of Functional Biomaterials · doi:10.3390/jfb14020086 · Cited by 23
Ma, Q., Rubenis, K., Sigurjónsson, Ó. E., Hildebrand, T., Standal, T., Zemjane, S., Ločs, J., Loča, D., & Haugen, H. J. (2023) · Smart Materials in Medicine · doi:10.1016/j.smaim.2023.04.001 · Cited by 24
Therapeutic Agent-Loaded Fibrous Scaffolds for Biomedical Applications
Park, D., Lee, S. J., Choi, D. K., & Park, J.-W. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051522 · Cited by 23
Chen, Y.-C., Lin, Y., Liu, C.-T., Liu, Y., Lin, M.-H., Lan, G., Cheng, Y., Yu, H.-L., Huang, C., Chang, H., et al. (2023) · ACS Applied Polymer Materials · doi:10.1021/acsapm.3c00146 · Cited by 23
Consumption of Phytoestrogens Affects Bone Health by Regulating Estrogen Metabolism
Tomczyk‐Warunek, A., Winiarska‐Mieczan, A., Blicharski, T., Blicharski, R., Kowal, F., Pano, I. T., Tomaszewska, E., & Muszyński, S. (2024) · Journal of Nutrition · doi:10.1016/j.tjnut.2024.05.026 · Cited by 23
Gallium-containing mesoporous nanoparticles influence in-vitro osteogenic and osteoclastic activity
Kurtuldu, F., Mutlu, N., Friedrich, R. P., Beltrán, A. M., Liverani, L., Detsch, R., Alexiou, C., Galusek, D., & Boccaccini, A. R. (2024) · Biomaterials Advances · doi:10.1016/j.bioadv.2024.213922 · Cited by 23
Nutrient and Hormonal Effects on Long Bone Growth in Healthy and Obese Children: A Literature Review
Hasan, S. M., Naseer, S., Zamzam, M. E., Mohilldean, H., Wagoner, C. V., Hasan, A. I., Saleh, E. S., Uhley, V. E., & Kamel-ElSayed, S. A. (2024) · Children · doi:10.3390/children11070817 · Cited by 23
Amorphous calcium phosphate (ACP) in tissue repair process
Allegrini, S., Junior, A. C. D. S., Tsujita, M., Salles, M. B., Gehrke, S. A., & Braga, F. J. C. (2018) · Microscopy Research and Technique · doi:10.1002/jemt.23013 · Cited by 23
Cuttlebone as a Marine-Derived Material for Preparing Bone Grafts
Palavenienė, A., Harkavenko, V. V., Kharchenko, V., Daugėla, P., Pranskūnas, M., Juodžbalys, G., Babenko, N. A., & Liesienė, J. (2018) · Marine Biotechnology · doi:10.1007/s10126-018-9816-6 · Cited by 23
Bone-implantable devices for drug delivery applications
Ray, P., Hasnain, M. S., Koley, A., & Nayak, A. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-102420-1.00021-2 · Cited by 23
Socio-economic Determinants of Bone Health from Past to Present
Miszkiewicz, J. J., & Cooke, K. M. (2019) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-019-09263-1 · Cited by 23
Lee, H.-R., Lee, K., Lee, S., Lee, J., Jeong, W. T., Lim, H. B., Hyun, T. K., Yi, S.-J., & Kim, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041347 · Cited by 23
Huang, L., Su, W., Wu, Z., Zheng, L., & Lv, C. (2022) · Cell Biology International · doi:10.1002/cbin.11783 · Cited by 23
Towards new material biomarkers for fracture risk
Greenwood, C., Clement, J. G., Dicken, A., Evans, P., Lyburn, I. D., Martin, R. M., Rogers, K. D., Stone, N., & Zioupos, P. (2016) · Bone · doi:10.1016/j.bone.2016.09.006 · Cited by 23
Shettigar, R. S., Swathika, R., Shetty, A., K, A. R. B., Aranjani, J. M., Mutalik, S., & Manikkath, J. (2025) · International Journal of Polymeric Materials · doi:10.1080/00914037.2025.2493910 · Cited by 22
Lopalco, G., Cito, A., Iannone, F., Diekhoff, T., Poddubnyy, D., & Proft, F. N. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1599995 · Cited by 22
Zong, B., Sun, W., Cai, C., & Shang, P. (2025) · Biomolecules · doi:10.3390/biom15101351 · Cited by 22
Yadav, L. R., Balagangadharan, K., Lavanya, K., & Selvamurugan, N. (2021) · Life Sciences · doi:10.1016/j.lfs.2022.120559 · Cited by 22
Alipal, J., Saidin, S., Abdullah, H. Z., Idris, M. I., & Lee, T. C. (2022) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2022.126543 · Cited by 22
Zhang, M., Yu, Y., He, D., Liu, D., & Zhou, Y. (2022) · Journal of the World Federation of Orthodontists · doi:10.1016/j.ejwf.2022.08.003 · Cited by 22
RUNX2 and ALP expression in osteoblast cells exposed by PMMA-HAp combination: An in vitro study
Darjanki, C. M., Prаhаsаnti, C., Augustina, E. F., Kusumawardani, B., Wijaksana, I. K. E., & Aljunaid, M. (2023) · Journal of Oral Biology and Craniofacial Research · doi:10.1016/j.jobcr.2023.02.007 · Cited by 22
Scaggion, C., Marinato, M., Sasso, G. D., Nodari, L., Saupe, T., Aneli, S., Pagani, L., Scheib, C. L., Rigo, M., & Artioli, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-51518-5 · Cited by 22
Self-citationBone tissue engineering for osteointegration: Where are we now?
Aykora, D., & Uzun, M. (2024) · Polymer Bulletin · doi:10.1007/s00289-024-05153-9 · Cited by 22
Ali, Z., Al-Ghouti, M. A., Abou-Saleh, H., & Rahman, M. M. (2024) · Marine Drugs · doi:10.3390/md22100446 · Cited by 22
Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them
Petrillo, A., Giunta, E. F., Pappalardo, A., Bosso, D., Attademo, L., Cardalesi, C., Diana, A., Fabbrocini, A., Fabozzi, T., Giordano, P., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081777 · Cited by 22
Drug Delivery to the Bone Microenvironment Mediated by Exosomes: An Axiom or Enigma
Samal, S., Dash, P., & Dash, M. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s307843 · Cited by 22
Exploring Quercetin Anti-Osteoporosis Pharmacological Mechanisms with In Silico and In Vivo Models
Hu, Y., Yuan, W., Cai, N., Jia, K., Meng, Y., Wang, F., Ge, Y., & Lu, H. (2022) · Life · doi:10.3390/life12070980 · Cited by 22
Involvement of the Notch signaling system in alveolar bone resorption
Jakovljević, A., Nikolić, N., Holtzman, L. P., Tournier, P., Gaudin, A., Cordaro, L., & Milinković, I. (2023) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2023.02.003 · Cited by 22
Circulating miRNAs: A New Opportunity in Bone Fragility
Donati, S., Ciuffi, S., Palmini, G., & Brandi, M. L. (2020) · Biomolecules · doi:10.3390/biom10060927 · Cited by 22
Critical roles of extracellular vesicles in periodontal disease and regeneration
Lin, J., Wang, H., Zhang, N., Zhang, W., Chen, Y., Deng, D., Li, X., Chen, F., & He, X. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szae092 · Cited by 21
Chitosan nanovectors for siRNA delivery: New horizons for nonviral gene therapy
Rahimi, M., Kariminezhad, Z., Rondon, E.-P., Fahmi, H., Fernandes, J., & Benderdour, M. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2025.123581 · Cited by 23
Function of hematopoiesis and bone marrow niche in inflammation and non-hematopoietic diseases
Wang, Y., Deng, Z., Li, Y.-Y., Bai, K., Ma, J., Liu, Y., & Chen, Q. (2025) · Life Medicine · doi:10.1093/lifemedi/lnaf015 · Cited by 21
Ibrahim, H.-I. M., Darrag, H. M., Alhajhoj, M. R., & Khalil, H. E. (2020) · Plants · doi:10.3390/plants9111610 · Cited by 21
Evaluating the Role of Probiotics in the Prevention and Management of Age-Related Diseases
Kiousi, D. E., Kouroutzidou, A. Z., Neanidis, K., Matthaios, D., Pappa, A., & Galanis, Α. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073628 · Cited by 21
Bone fragility: conceptual framework, therapeutic implications, and COVID-19-related issues
Iolascon, G., Paoletta, M., Liguori, S., Gimigliano, F., & Moretti, A. (2022) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x221133429 · Cited by 21
Denosumab use in osteogenesis imperfecta: an update on therapeutic approaches
Majdoub, F., Ferjani, H. L., Nessib, D. B., Kaffel, D., Maatallah, K., & Hamdi, W. (2023) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2346058.029 · Cited by 21
TMBIM6 deficiency leads to bone loss by accelerating osteoclastogenesis
Yi, S.-J., Jang, Y.-J., Lee, S., Cho, S., Kang, K., Park, J.-I., Chae, H., Kim, H., & Kim, K. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102804 · Cited by 21
Dixon, D. T., Landree, E. N. N., & Gomillion, C. T. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c00236 · Cited by 21
Nanofibrous Microspheres: A Biomimetic Platform for Bone Tissue Regeneration
Desai, N., Pande, S., Vora, L. K., & Kommineni, N. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c00613 · Cited by 21
Exploring the Potential of Nano-Biomaterials in Tissue Engineering
Pandey, G., Kolipaka, T., Phatale, V., Khairnar, P., Abraham, N., Shah, S., Famta, P., Vambhurkar, G. B., Srinivasarao, D. A., Saraf, S., et al. (2024) · Springer eBooks · doi:10.1007/978-981-97-3925-7_2 · Cited by 21
Tan, X., Huang, D., Zhou, W., Li, Y., Yue, J., Lu, W., Song, D., Zhou, X., Ye, L., & Zhang, L. (2017) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2017.11.012 · Cited by 21
Gupta, D., Grant, D. M., Hossain, K. M. Z., Ahmed, I., & Sottile, V. (2017) · Journal of Biomaterials Applications · doi:10.1177/0885328217745699 · Cited by 21
Brodetska, L., Натрус, Л. В., Lisakovska, O., Канюра, О. А., Iakovenko, L., Skrypnyk, I. L., & Flis, P. (2020) · BMC Oral Health · doi:10.1186/s12903-020-01251-y · Cited by 21
Pinto, S. A. D. A., Dias, F. J. D. N., Cardoso, G. B. C., Santos, A. R., de Aro, A. A., Pino, D. S., Meneghetti, D. H., Vitti, R. P., dos Santos, G. M. T., & Zavaglia, C. A. D. C. (2021) · Cells Tissues Organs · doi:10.1159/000511570 · Cited by 21
Distinct Effects of a High Fat Diet on Bone in Skeletally Mature and Developing Male C57BL/6J Mice
Ross, D., Yeh, T.-H., King, S., Mathers, J., Rybchyn, M. S., Neist, E., Cameron, M. S., Tacey, A., Girgis, C. M., Levinger, I., et al. (2021) · Nutrients · doi:10.3390/nu13051666 · Cited by 21
Bjelić, D., & Finšgar, M. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106060 · Cited by 21
Examining the role of cannabinoids on osteoporosis: a review
Clouse, G., Penman, S. L., Hadjiargyrou, M., Komatsu, D. E., & Thanos, P. K. (2022) · Archives of Osteoporosis · doi:10.1007/s11657-022-01190-x · Cited by 21
Nezhad, A. H. N., Zahrani, E. M., Mousavinasab, S., & Alfantazi, A. M. (2025) · Journal of Materials Research and Technology · doi:10.1016/j.jmrt.2025.05.069 · Cited by 20
Tooth-derived stem cells integrated biomaterials for bone and dental tissue engineering
Vimalraj, S., & Sekaran, S. (2023) · Cell and Tissue Research · doi:10.1007/s00441-023-03815-0 · Cited by 20
A Microfluidic Organ-On-A-Chip: Into the Next Decade of Bone Tissue Engineering Applied in Dentistry
Syahruddin, M. H., Anggraeni, R., & Ana, I. D. (2023) · Future Science OA · doi:10.2144/fsoa-2023-0061 · Cited by 20
Kohestani, A. A., & Pishbin, F. (2023) · Advanced Engineering Materials · doi:10.1002/adem.202300563 · Cited by 20
Kondi, S., & Gowda, S. R. (2023) · Surgery (Oxford) · doi:10.1016/j.mpsur.2023.08.002 · Cited by 20
Metals accumulation affects bone and muscle in osteoporotic patients: A pilot study
Battistini, B., Greggi, C., Visconti, V. V., Albanese, M., Messina, A., Filippis, P. D., Gasperini, B., Falvino, A., Piscitelli, P., Palombi, L., et al. (2024) · Environmental Research · doi:10.1016/j.envres.2024.118514 · Cited by 20
Paola, A. D., Marrapodi, M. M., Martino, M. D., Giliberti, G., Feo, G. D., Rana, D., Ahmed, S., Argenziano, M., Rossi, F., & Roberti, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052902 · Cited by 20
Habiburrohman, M. R., Jamilludin, M. A., Cahyati, N., Herdianto, N., & Yusuf, Y. (2025) · RSC Advances · doi:10.1039/d4ra08457h · Cited by 20
Ranat, K., Phan, H., Ellythy, S., Kenter, M., & Akkouch, A. (2025) · Journal of Functional Biomaterials · doi:10.3390/jfb16050163 · Cited by 20
Liu, C., Cao, Z., Zhang, W., Tickner, J. C., Qiu, H., Wang, C., Chen, K., Wang, Z., Tan, R. X., Dong, S., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26841 · Cited by 20
Limraksasin, P., Okawa, H., Zhang, M., Kondo, T., Osathanon, T., Pavasant, P., & Egusa, H. (2020) · Stem Cells International · doi:10.1155/2020/7082679 · Cited by 20
Papadogiannis, F., Batsali, A. K., Klontzas, M. E., Karabela, M. M., Georgopoulou, Α., Mantalaris, A., Zafeiropoulos, N. E., Chatzinikolaidou, Μ., & Pontikoglou, C. (2020) · Biomedical Materials · doi:10.1088/1748-605x/aba325 · Cited by 20
Valencia-Llano, C. H., Solano, M. A., & Grande‐Tovar, C. D. (2021) · Polymers · doi:10.3390/polym13223877 · Cited by 20
Circulating Exosomes from Mice with LPS-Induced Bone Loss Inhibit Osteoblast Differentiation
Wang, Y., Zhang, L., Wang, K., Zhou, H., Li, G., Xu, L., Hu, Z., Cao, X., Shi, F., & Zhang, S. (2022) · Calcified Tissue International · doi:10.1007/s00223-022-00977-x · Cited by 20
Yoon, D. S., Choi, Y., Lee, K., Ko, E. A., Kim, E., Park, K. H., & Lee, J. W. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00920-8 · Cited by 20
Liu, Y., Chen, Y., Li, X., Li, T.-P., Cao, C., Zhang, H.-X., Zhou, C., Chen, Y., Gong, Y., Wang, Z., et al. (2023) · International Journal of Stem Cells · doi:10.15283/ijsc22101 · Cited by 20
Alendronate alters osteoblast activities
Krüger, T. B., Herlofson, B. B., Landin, M. A., & Reseland, J. E. (2016) · Acta Odontologica Scandinavica · doi:10.1080/00016357.2016.1217041 · Cited by 20
Parathyroid Embryology, Anatomy, and Pathophysiology of Primary Hyperparathyroidism
Arrangoiz, R., Cordera, F., Caba, D., Muñoz-Juárez, M., Moreno, E., & Luque, E. (2017) · International Journal of Otolaryngology and Head & Neck Surgery · doi:10.4236/ijohns.2017.64007 · Cited by 20
Ahn, S. H., Chen, Z., Lee, J., Lee, S., Min, S. H., Kim, N. D., & Lee, T. (2018) · Molecules · doi:10.3390/molecules23123139 · Cited by 20
Li, X., Dongyue, Z., Yang, D., Fu, Y., Tao, X., Hu, X., Dai, Y., & Yue, H. (2022) · Molecules · doi:10.3390/molecules27113459 · Cited by 19
Kim, H., Oh, N., Kwon, M., Kwon, O.-H., Ku, S., Seo, J., & Roh, S. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03151-0 · Cited by 19
Ghuloum, F. I., Johnson, C. A., Galdo, N. A. R., & Amer, M. H. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100502 · Cited by 19
Arnold, K. M., Sicard, D., Tschumperlin, D. J., & Westendorf, J. J. (2023) · Sensors · doi:10.3390/s23041835 · Cited by 19
Sapasakulvanit, S., Teoh, J. H., & Ferrand, H. L. (2024) · Matter · doi:10.1016/j.matt.2024.09.011 · Cited by 19
The Impact of Fermented Dairy Products and Probiotics on Bone Health Improvement
Bashir, H. H., Hasnain, M. A., Abbas, A., Lee, J.-H., & Moon, G. (2025) · Food Science of Animal Resources · doi:10.5851/kosfa.2025.e7 · Cited by 19
Enhanced functionalities of biomaterials through metal ion surface modification
Tao, Y., Ayre, W. N., Jiang, L., Chen, S., Dong, Y., Wu, L. J., Jiao, Y., & Liu, X. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1522442 · Cited by 19
Ihn, H. J., Kim, J., Cho, H. S., Shin, H., Kim, G., Choi, Y. H., Jeon, Y., & Park, E. K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122635 · Cited by 19
Flaxseed (linum usitatissimum) flour contributes to bone health in adult male rats
Maíra, D. C. D. A., Pessôa, L. R., da Costa, L. R., Boueri, B. F. D. C., Pessanha, C. R., Pereira, A. D., Ribeiro, D. C., da Silva, E. M., da Costa, C. A. S., & Boaventura, G. T. (2017) · Nutrition · doi:10.1016/j.nut.2017.11.025 · Cited by 19
Kuttappan, S., Anitha, A., Minsha, M. G., Menon, P. M., Sivanarayanan, T. B., Vijayachandran, L. S., & Nair, M. B. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.01.001 · Cited by 19
Metadata
- Authors
- Florencio-Silva, R., Sasso, G. R. D. S., Sasso-Cerri, E., Simões, M. J., & Cerri, P. S.
- Affiliations
- Department of Morphology and Genetics, Laboratory of Histology and Structural Biology, Federal University of São Paulo, 04023-900 São Paulo, SP, Brazil
- Universidade Federal de São Paulo (BR)
- Department of Morphology, Laboratory of Histology and Embryology, Dental School, Universidade Estadual Paulista (UNESP), 14801-903 Araraquara, SP, Brazil
- Universidade Estadual Paulista (Unesp) (BR)
- Corresponding author
- Cerri, Paulo Sérgio
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-17
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4515490
- OpenAlex
- W1594526962
- Cited by
- 2,044
- References
- 209
- Citations by year
- 2026: 157 · 2025: 238 · 2024: 265 · 2023: 286 · 2022: 254 · 2021: 241 · 2020: 219 · 2019: 169 · 2018: 110 · 2017: 64 · 2016: 35 · 2015: 5
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Americanae (AECID Library) (publishedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Acervo Digital da Universidade Estadual Paulista (Universidade Estadual Paulista) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2010/10391-9, 2012/19428-8, 2012/22666-8)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (2010/10391-9, 2012/19428-8, 2012/22666-8)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (2010/10391-9, 2012/19428-8, 2012/22666-8)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Keywords
- bone remodeling, bone cells, osteoclasts, osteoblasts, osteocytes, bone resorption, bone formation, bone homeostasis, osteocyte apoptosis, osteoporosis, calcitonin, estrogen, growth factors, cytokines, mechanosensing, intercellular communication
- MeSH terms
- Animals, Bone and Bones, Calcification, Physiologic, Cell Communication, Humans, Models, Biological, Osteoblasts, Osteoclasts, Structure-Activity Relationship, Bone Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.